Delphi advisor to ProstaLund in connection with reverse share split

Delphi has assisted ProstaLund AB (publ) in connection with a reverse share split, whereby forty (40) shares became one (1) share (reverse split 1:40).

ProstaLund is a Swedish medical technology company. The company develops innovative products and treatments in the field of urology. ProstaLund is listed on the Nasdaq First North Growth Market.

Delphi’s team consisted of Micael Karlsson, Ludvig Borg and Elfie Ekegren Franzetti.